Undifferentiated Gastric Carcinoma
NCI Definition: A carcinoma that arises from the stomach and is characterized by the absence of microscopic features of glandular or squamous differentiation. 
There are 2 clinical trials for undifferentiated gastric carcinoma, of which 1 is open and 1 is completed or closed. Of the trials that contain undifferentiated gastric carcinoma as an inclusion criterion, 1 is phase 1/phase 2 (0 open) and 1 is phase 3 (1 open).
Avelumab, carboplatin, and paclitaxel are the most common interventions in undifferentiated gastric carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.